MoU signing and Malaysia Book of Records recognition underscore sustained consumer trust for ELDON, at a time when Malaysians ...
Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patientsIngelheim, ...
New Study Reveals U.S. Businesses Average Over 5 Major Outages Annually, with 63% Occurring During Critical Peak Trading ...
X is excited to announce the new 1X World Model, a groundbreaking AI update for NEO, marking a major leap forward in humanoid ...
Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, ...
ISAC’s expansion into the APAC region, enhancing cybersecurity and resilience in the global health sectorSINGAPORE, Jan. 11, ...
Investment industry veteran Mr. Brian Cherry appointed to Board of DirectorsDr. Sabeen Mekan to transition to Chief Medical ...
Today, the LEGO Group and The Pokémon Company International are unveiling the first ever collection of highly anticipated ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Richard Francis, Teva's President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, ...
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an ...
The Next RegimeHONG KONG SAR - - 13 January 2026 - Today, KGI has released its 2026 Global Market Outlook, covering markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback